An observational study to investigate the safety and efficacy of niraparib for Japanese patients with recurrent ovarian cancer: maintenance therapy for platinum-sensitive recurrent treatment and monotherapy for late-line treatment
Not Applicable
Recruiting
- Conditions
- Ovarian cancer, fallopian tube cancer, primary peritoneal cancer
- Registration Number
- JPRN-UMIN000046970
- Lead Sponsor
- Japanese Gynecologic Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with active double cancer 2.Patients judged by the investigator to be inappropriate for participation in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method